| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 138.88B | 131.69B | 133.39B | 121.56B | 98.44B | 81.53B |
| Gross Profit | 38.48B | 34.93B | 39.29B | 38.99B | 35.23B | 25.62B |
| EBITDA | 8.03B | 5.38B | 4.60B | 7.08B | 4.47B | 23.01B |
| Net Income | 67.00M | 1.14B | 987.00M | 2.74B | 919.00M | 12.83B |
Balance Sheet | ||||||
| Total Assets | 102.14B | 105.96B | 109.89B | 108.92B | 97.80B | 105.11B |
| Cash, Cash Equivalents and Short-Term Investments | 28.36B | 35.69B | 47.08B | 48.14B | 44.67B | 52.65B |
| Total Debt | 1.75B | 258.00M | 200.00M | 206.00M | 107.00M | 136.00M |
| Total Liabilities | 51.35B | 54.85B | 53.79B | 50.08B | 37.10B | 46.76B |
| Stockholders Equity | 49.74B | 50.11B | 55.19B | 58.07B | 57.87B | 55.42B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -7.37B | 133.00M | 5.61B | -7.42B | -10.85B |
| Operating Cash Flow | 0.00 | -4.67B | 3.69B | 9.19B | -4.46B | -6.48B |
| Investing Cash Flow | 0.00 | 928.00M | -2.40B | -3.13B | -3.39B | 70.04B |
| Financing Cash Flow | 0.00 | -7.01B | -2.36B | -2.49B | -314.00M | -28.93B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | ¥185.70B | 16.53 | ― | 1.17% | 53.21% | 65.83% | |
77 Outperform | ¥418.91B | 15.93 | ― | 0.33% | 6.38% | 38.69% | |
67 Neutral | ¥15.19B | 11.93 | ― | 1.40% | 26.47% | 55.11% | |
66 Neutral | ¥572.17B | 28.18 | ― | 1.12% | 5.90% | 17.39% | |
60 Neutral | $48.67B | 4.58 | -11.27% | 4.14% | 2.83% | -41.78% | |
59 Neutral | ¥26.97B | 124.21 | ― | 1.11% | -4.66% | -56.66% | |
49 Neutral | ¥54.46B | 6.12 | 4.10% | 4.16% | 11.52% | 162.04% |